Clinical guidance on the Management of Acute and Chronic Harms of Club Drugs and NPS training for psychiatrists and narcologists II

 

For three days, from Wednesday 5th to Friday 7th of May 2021, a second NEPTUNE Clinical guidance on the Management of Acute and Chronic Harms of Club Drugs and New Psychoactive Substances training took place in Georgia for psychiatrists and narcologists.

The first training had taken place from 26th to 28th of April. Both trainings in April and May were organised by the Centre for Mental Health and Prevention of Addiction (CMHPA), Georgia, with the support of the EU4 Monitoring Drugs (EU4MD) Project of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the EU Action against drugs and organised crime (EU-ACT) Project; but in contrast with the first training of April, this second one in May took a remote format for all participants due to more restricted COVID rules enforced in Georgia in May 2021.

These two training activities have been a continuation of the training for trainers sessions organised jointly by EU4MD and EU-ACT about the NEPTUNE Clinical guidance on the Management of Acute and Chronic Harms of Club Drugs and New Psychoactive Substances which were delivered by the Novel Psychoactive Treatment UK Network (NEPTUNE) team from the Central and North West London NHS Foundation Trust, remotely, on 30th of July 2020 (appraisal meeting with the Georgian specialists), 7th, 12th, 19th of October, and 3rd of November 2020, as train-of-trainer’s sessions.

The 5th-7th of May 2021’s training activity in Georgia was addressed to a group of 23 specialists from the CMHPA and private narcological facilities. The Georgian trainers were again the same three CMHPA’s specialists who were trained by the NEPTUNE experts in the train-of-trainers’ sessions in 2020: Natia Loladze, Olga Kukhianidze, and Tamar Aladashvili.

The Director of the Georgian Centre for Mental Health and Prevention of Addiction (CMHPA), Mr. Lasha Kiladze opened this May's event, while it was closed by its Deputry Director Mr. Guri Menabdishvili. The opening and closing ceremonies were also attended remotely by representatives from EMCDDA, EU-ACT and NEPTUNE. The lectures and presentations were delivered by the Georgian trainers in Georgian language. The interventions of the NEPTUNE Team at the opening and closing sessions were delivered in English with simultaneous translation into Georgian.

As in the previous event in April, the EU-ACT team in Georgia attended, coordinated, and moderated the May’s sessions.

The training dealt with the pharmacology and characteristics of acute and chronic toxicity, and harm management of the NPS and Club drugs, sorted into depressants, stimulants, hallucinogens, and synthetic cannabinoid receptor agonists (SCRAs).

On Thursday, 6th, there was also a presentation by Georgian National Drug Observatory’s representatives.

The NEPTUNE Project team provided and overview of the new psychoactive substances (NPS) guidance and its development, and at the end of the last session there was a plenary discussion with simultaneous interpretation attended by Professor Mr. Owen Bowden-Jones and Doctor Ms. Dima Abdulrahim, from the NEPTUNE team, where participants could raise questions directly to the NEPTUNE representatives.